Maxwell A. Gyamfi

2.4k citations
35 papers · 2.0k indexed · 1 hit paper · h-index 22
Topics
Peroxisome Proliferator-Activated Receptors (10 papers)Liver Disease Diagnosis and Treatment (9 papers)Pharmacogenetics and Drug Metabolism (8 papers)

In The Last Decade

Maxwell A. Gyamfi

34 papers receiving 1.9k citations

Hit Papers

Free-radical scavenging action of medicinal herbs from Ghana19992026200820171999250500750

Peers

Maxwell A. Gyamfi
Comparison fields: 5 of 109
  • Molecular Biology 682
  • Plant Science 483
  • Biochemistry 433
  • Epidemiology 374
  • Endocrinology, Diabetes and Metabolism 359
Replace Hesham A. El-Beshbishy with:
Hesham A. El-Beshbishy Egypt
N. Nalini India
Szu‐Chuan Shen Taiwan
Song‐Hae Bok South Korea
Ka Ying Hong Kong
Woojin Jun South Korea
Myung-Sook Choi South Korea
Milagros Galisteo Spain
Shizuka Hirai Japan
Haibo Wang China
Maxwell A. Gyamfi relative to Hesham A. El-Beshbishy Egypt Hesham A. El-Beshbishy's profile →
Citations per field
00.5×1.5×2.4×
Hesham A. El-Beshbishy · 1×
Citations per year

Countries citing papers authored by Maxwell A. Gyamfi

Since Specialization
Citations

This map shows the geographic impact of Maxwell A. Gyamfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxwell A. Gyamfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxwell A. Gyamfi more than expected).

Fields of papers citing papers by Maxwell A. Gyamfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxwell A. Gyamfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxwell A. Gyamfi. The network helps show where Maxwell A. Gyamfi may publish in the future.

Co-authorship network of co-authors of Maxwell A. Gyamfi

This figure shows the co-authorship network connecting the top 25 collaborators of Maxwell A. Gyamfi. A scholar is included among the top collaborators of Maxwell A. Gyamfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxwell A. Gyamfi. Maxwell A. Gyamfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 4
4 5
5 21
6 42
7 15
8 25
9 14
10 33
11 81
12 17
13 215
14 47
15 44
16 30
17 29
18 7
19 86
20 52

About Maxwell A. Gyamfi

Maxwell A. Gyamfi is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Biochemistry (433 citations), Pharmacology (335 citations) and Endocrinology, Diabetes and Metabolism (359 citations). Maxwell A. Gyamfi has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Yoko Aniya, Masato Yonamine, Yu‐Jui Yvonne Wan, Curtis D. Klaassen, Lin He, Frank J. Gonzalez, Ronnie L. Yeager, Yuji Tanaka, Grace L. Guo and Lauren M. Aleksunes. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026